Operating cash flow of $535.6M converted at 4.99x net income in 2026Q3, funding $478.8M of cumulative buybacks over ten quarters as provision relief of ~$137.6M per quarter freed organic origination capacity.
Enova International, Inc. (ENVA) cash flow statement — 17-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|
| Cash from Operations | 2.05B | 1.82B | 1.54B | 1.17B | 894M | 471.87M | 740.87M | 875.62M | 684.84M | 447.17M | 393.37M | 283.92M | 422.07M | 438.3M | 375.51M | 257.94M | 218.45M | 150.88M |
| Operating CF Growth % | 69.96% | 18.23% | 31.86% | 30.52% | 89.46% | -36.31% | -15.39% | 27.86% | 53.15% | 13.68% | 38.55% | -32.73% | -3.7% | 16.72% | 45.58% | 18.08% | 44.79% | - |
| Net Income | 382.44M | 308.39M | 209.45M | 175.12M | 207.42M | 257.07M | 377.93M | 36.61M | 70.1M | 29.24M | 34.6M | 43.99M | 111.67M | 78.04M | 58.87M | 37.03M | 24.82M | 17.7M |
| Depreciation & Amortization | 37.01M | 41.83M | 40.21M | 38.16M | 36.87M | 35.38M | 19.73M | 15.05M | 14.2M | 14.39M | 15.56M | 18.39M | 18.73M | 17.14M | 13.27M | 11.26M | 8.56M | 7.3M |
| Deferred Taxes | 81.11M | 70.56M | 112.72M | 8.54M | 17.03M | 39.31M | 3.24M | 0 | 21.97M | -4.74M | -2.2M | -1.4M | 12.14M | 5.24M | -2.42M | 2.45M | 2.86M | 3.36M |
| Other Non-Cash Items | 1.49B | 1.33B | 1.16B | 889.76M | 619.31M | 177.75M | 247.03M | 861.35M | 603.24M | 429.03M | 338.03M | 221.21M | 268.3M | 335.1M | 309.48M | 219.13M | 180.46M | 121.15M |
| Working Capital Changes | 22.19M | 32.72M | -14.03M | 28.55M | -8.59M | -58.81M | 74.9M | -49.37M | -36.33M | -32.05M | -1.14M | -7.9M | 10.56M | 2.53M | -3.83M | -12.1M | 1.68M | 1.28M |
| Cash from Investing | -3.03B | -2.45B | -1.91B | -1.49B | -1.67B | -980.37M | 83.58M | -941.4M | -720.93M | -527.13M | -484.58M | -372.17M | -305.23M | -403.74M | -365.52M | -281.29M | -224.91M | -179.22M |
| Purchase of Investments | -4.54B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -703K | 0 | -1M | 0 | 0 | 0 |
| Sale/Maturity of Investments | 3.09B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Investment Activity | -1.45B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -703K | 0 | -1M | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 8.71M | -27.23M | 109.92M | 0 | 0 | 0 | 0 | -17.73M | 0 | 0 | 0 | 0 | -21.16M | -42.45M |
| Other Investing | -1.53B | -2.4B | -1.87B | -1.45B | -1.63B | -923.47M | 3.15M | -921.34M | -704.85M | -510.61M | -470.18M | -322.19M | -291.24M | -388.87M | -346.64M | -266.21M | -191.06M | -124.42M |
| Cash from Financing | 1.11B | 711.82M | 318.88M | 526.54M | 724.87M | 365.15M | -535.97M | 95.48M | 22.48M | 104.58M | 99.88M | 56.62M | -79.04M | -28.57M | -9.01M | 43.12M | -1.03M | 39.32M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -122.38M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -140.98M | -214.59M | -289.29M | -153.19M | -143.07M | -116.66M | -56.41M | -33.78M | -17.31M | -5.08M | -437K | -187K | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 7.02M | 8.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Stock Activity | -133.95M | -205.88M | -289.29M | -153.19M | -143.07M | -116.66M | -56.41M | -33.78M | -17.31M | -5.08M | -437K | -187K | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 4M | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 0 | 1000K | -1000K | 1000K |
| Other Financing | -24.53M | -15.86M | -15.87M | -16.78M | -3.23M | 9.23M | -1.03M | -1.34M | -25.1M | -31.33M | -6.7M | -1.6M | -18.7M | -5.02M | -9.01M | 425K | 0 | 0 |
| Net Change in Cash | 139.44M | 85.19M | -54.77M | 199.04M | -47.48M | -143.32M | 288.24M | 30.68M | -20.89M | 28.75M | -2.13M | -33.04M | 27.63M | 9.93M | 3.14M | 18.97M | -8.07M | 10.77M |
| Exchange Rate Effect | -539K | 39K | -1.03M | 287K | -77K | 34K | -244K | 979K | -7.27M | 4.13M | -10.81M | -1.41M | -10.17M | 3.94M | 2.15M | -805K | -582K | -212K |
| Cash at Beginning | 465.21M | 322.67M | 377.44M | 178.4M | 225.88M | 369.2M | 80.96M | 50.28M | 98.14M | 39.93M | 42.07M | 75.11M | 47.48M | 37.55M | 34.41M | 19.19M | 27.26M | 16.5M |
| Cash at End | 496.4M | 407.86M | 322.67M | 377.44M | 178.4M | 225.88M | 369.2M | 80.96M | 77.26M | 68.68M | 39.93M | 42.07M | 75.11M | 47.48M | 37.55M | 38.16M | 19.19M | 27.26M |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 71.1M | 74.9M | 70.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Taxes Paid | 0 | 0 | 0 | 0 | 0 | 89.27M | 27.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 2.01B | 1.77B | 1.5B | 1.12B | 850.37M | 442.19M | 711.38M | 855.55M | 668.76M | 430.64M | 378.98M | 251.68M | 408.78M | 423.43M | 357.64M | 242.87M | 205.77M | 138.52M |
| FCF Growth % | 17.66% | 18.51% | 33.3% | 31.9% | 92.31% | -37.84% | -16.85% | 27.93% | 55.29% | 13.63% | 50.58% | -38.43% | -3.46% | 18.4% | 47.26% | 18.03% | 48.55% | - |
Quick answers to the most common questions about buying ENVA stock.
Enova International, Inc. (ENVA) generated $1.82B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Enova International, Inc. (ENVA) generated $1.77B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Enova International, Inc. (ENVA) spent $47.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Enova International, Inc. (ENVA) spent $214.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Regulatory rate-cap overhang
Metrics are mathematically derived from official filings.
Cash Conversion Far Exceeds Earnings
Enova's operating cash flow-to-net income ratio oscillated between 4.99x and 9.18x over ten quarters, with OCF expanding from $360.9M in 2024Q2 to $535.6M in 2026Q3 per SEC filings; the extreme multiple reflects the loan-originating business model, not traditional operating efficiency.
The persistently high OCF/NI ratio is characteristic of balance-sheet lenders, where cash inflows from receivable collections and origination premiums far exceed accounting net income distorted by CECL provisions. However, the declining ratio trend from 9.18x (2024Q3) to 4.99x (2026Q3) alongside doubling net income suggests the business is transitioning from a provisioning drag phase to genuine earnings-driven cash generation. Investors should note that the ~48% OCF growth substantially lags the ~99% net income growth over the same period, indicating the earnings inflection is outpacing the cash conversion improvement.
Originations Funded Without Financing Strain
Loan loss provisions peaked at $428.9M in 2025Q3 and declined 32% to $291.3M by 2026Q3, freeing approximately $137.6M in quarterly cash headroom, as reported in Enova's cash flow statements; this provision relief appears to be funding buybacks and origination growth organically.
The provision trajectory directly aligns with the prior income statement finding that roughly two-thirds of operating income improvement since 2024Q2 stems from lower reserves rather than revenue growth. The only negative provision quarter (-$85.1M in 2026Q1) coincided with the lowest net income ($91.1M) of the recent quarters, suggesting a reserve release may have been offset by non-cash mark-to-market adjustments or origination timing effects. This pattern reinforces that Enova's cash flow strength is credit-cycle dependent rather than structurally assured.
Securities Portfolio Activity Emerges Suddenly
Purchase and sale of investments first appear in 2026Q2 and 2026Q3, with $2.1B–$2.4B in purchases and $1.5B–$1.6B in sales, based on Enova's reported figures; this sudden gross activity suggests a new hedging or liquidity management strategy not present in the prior eight quarters.
The near-simultaneous appearance of large gross purchases and sales with modest net outflows ($500M–$800M net) is consistent with short-duration securities portfolio turnover, possibly driven by AOCI management or regulatory liquidity requirements. The complete absence of these line items in prior quarters warrants investigation into whether this reflects a genuine balance sheet strategy shift or an accounting reclassification. Given the elevated leverage profile, any material securities portfolio build could signal either prudent liquidity management or a defensive posture against funding cost volatility.
Buybacks Remain Sole Capital Return Channel
Enova has returned capital exclusively through buybacks, totaling $478.8M over ten quarters with zero dividends ever paid, per Enova's cash flow disclosures; the pace fluctuated from $19.8M (2026Q2) to $85.5M (2025Q1), suggesting discretionary allocation rather than a systematic repurchase program.
The absence of any dividend in a sector where peers like Regional Management (3.6% yield) and QCR Holdings (0.2% yield) return cash directly signals management's preference for EPS accretion over income-oriented investors. The decline in buyback pace during 2026 ($19.8M–$46.3M per quarter) alongside strengthening OCF may indicate either share price appreciation reducing repurchase attractiveness or a strategic decision to retain capital against potential regulatory uncertainty. Given the 24.3% ROE and elevated leverage, the lack of a dividend floor could limit downside support in a credit downturn.
Cash Flow Statement Obscures Credit Quality
The cash flow statement's investing activities reflect net loan book changes but cannot distinguish between genuine origination growth and portfolio runoff, as Enova's reported $107.3M net income in 2026Q3 appears alongside $535.6M OCF; the true credit health requires balance sheet loan-level disclosure not visible here.
The absence of purchase/sale of investments in eight of ten quarters suggests either a simplified cash flow presentation or a genuinely static securities portfolio, but the sudden appearance in 2026 creates an analytical blind spot about whether prior periods netted these activities. Furthermore, the CECL growth paradox noted in prior analysis means that strong origination quarters mechanically depress cash flow through day-one provisions, making OCF a lagging indicator of business health. Investors should rely on receivable vintage cohort data and NCO ratios rather than the cash flow statement alone to assess whether the current cash generation is sustainable through a full credit cycle.